← Back to Search

Other

DAIN Diet for Crohn's Disease (DAIN Trial)

N/A
Recruiting
Led By Ana L Maldonado-Contreras, PhD
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 0, 6, 10, 14
Awards & highlights

DAIN Trial Summary

This trial studies a diet intervention to treat Crohn's disease in Puerto Ricans, based on the IBD-AID™ diet, with traditional foods.

Who is the study for?
This trial is for adults aged 21-65 with mild to moderate Crohn's disease who are willing to significantly change their diet. Participants must have stable medication doses and be able to follow study procedures. Those on high-dose steroids, recent C. difficile colitis, ostomies, or using certain diets or probiotics within the last month cannot join.Check my eligibility
What is being tested?
The DAIN dietary intervention is being tested for its effectiveness in treating Crohn's disease symptoms. It adapts the IBD-AID™ by incorporating Puerto Rican food preferences while keeping key anti-inflammatory components intact.See study design
What are the potential side effects?
Since this trial involves a dietary intervention (DAIN), side effects may include changes in digestion such as discomfort or altered bowel habits as participants adjust to new foods.

DAIN Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 0, 6, 10, 14
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 0, 6, 10, 14 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical response and remission
Secondary outcome measures
Change of Inflammation
Dietary compliance
Gut Microbiome changes

DAIN Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm1: Crohn's disease patients + DAINExperimental Treatment1 Intervention
Participants will have 10 weeks of DAIN intervention (From week 1 to week 10)
Group II: Arm 2: Crohn's disease patients no interventionActive Control1 Intervention
Participants will continue consuming their usual diet, with no intervention

Find a Location

Who is running the clinical trial?

University of Massachusetts, WorcesterLead Sponsor
345 Previous Clinical Trials
989,297 Total Patients Enrolled
University of Puerto RicoOTHER
62 Previous Clinical Trials
20,680 Total Patients Enrolled
The Leona M. and Harry B. Helmsley Charitable TrustOTHER
57 Previous Clinical Trials
93,736 Total Patients Enrolled

Media Library

DAIN (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05627128 — N/A
Crohn's Disease Research Study Groups: Arm1: Crohn's disease patients + DAIN, Arm 2: Crohn's disease patients no intervention
Crohn's Disease Clinical Trial 2023: DAIN Highlights & Side Effects. Trial Name: NCT05627128 — N/A
DAIN (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05627128 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I meet the criteria to take part in this research program?

"The trial is searching for 150 participants, aged 21 to 65 years old, who are suffering from ileocolitis."

Answered by AI

Does the current research include elderly participants?

"The criteria for enrolment in this clinical trial necessitates that patients must be aged between 21 and 65."

Answered by AI

Is recruitment still underway for this clinical investigation?

"According to the data available on clinicaltrials.gov, this study is presently recruiting volunteers and has been since its launch date of September 6th 2022. The most recent update was made on November 15th 2022."

Answered by AI
~62 spots leftby Jul 2025